Epithalon (Epitalon)

Mechanism of Action

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide -- Ala-Glu-Asp-Gly -- developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology.

Key mechanisms:

• Telomerase activation -- Epithalon upregulates telomerase (hTERT), the enzyme responsible for maintaining telomere length. Telomere shortening is one of the primary hallmarks of cellular ageing
• Pineal gland regulation -- stimulates melatonin secretion, normalising circadian rhythm disruptions common with advancing age
• Antioxidant effect -- reduces lipid peroxidation and oxidative stress in multiple tissue types
• Neuroendocrine restoration -- modulates the hypothalamic-pituitary axis, supporting hormonal homeostasis

Human Evidence

In a 12-year longitudinal study of 266 elderly patients (St. Petersburg), the Epithalamin group showed a 28% reduction in mortality versus controls. A separate study demonstrated telomere elongation in human somatic cells in vitro -- the key mechanistic finding that distinguishes this compound from other longevity peptides.

Dosing Protocol

Standard cycle: 10mg/day subcutaneous for 10-20 consecutive days, repeated 2-3 times per year.

Khavinson protocol (original): 5-10mg/day for 10 days, twice per year (spring and autumn).

Why This Belongs in the Longevity Section

No other supplement-accessible compound has published human data on actual telomere elongation. Epithalon remains a unique compound in the longevity toolkit.